Cité dans 3 publications.
Cet anticorps anti-C1q Polyclonal Mouton conjugué à FITC (ABIN2477784) détecte spécifiquement C1q dans IHC (fro).
L’anticorps est réactif avec des échantillons de Humain.
Optimal working dilution should be determined by the investigator.
Restrictions
For Research Use only
Format
Liquid
Concentration
10 mg/mL
Hwang, Duvall, Tomlinson, Boackle et al.: "Highly specific inhibition of C1q globular-head binding to human IgG: a novel approach to control and regulate the classical complement pathway using an engineered single chain antibody variable ..." dans: Molecular immunology, Vol. 45, Issue 9, pp. 2570-80, (2008) (PubMed).
Cragg, Glennie: "Antibody specificity controls in vivo effector mechanisms of anti-CD20 reagents." dans: Blood, Vol. 103, Issue 7, pp. 2738-43, (2004) (PubMed).
Sárvári, Vágó, Wéber, Nagy, Gál, Mák, Kósa, Závodszky, Pázmány: "Inhibition of C1q-beta-amyloid binding protects hippocampal cells against complement mediated toxicity." dans: Journal of neuroimmunology, Vol. 137, Issue 1-2, pp. 12-8, (2003) (PubMed).